Welcome to the EPCCS
The First Pan-European society for healthcare professionals focusing on the management of cardiovascular disease
Welcome to the website of the
European
Primary
Care
Cardiovascular
Society(
EPCCS). The EPCCS, founded in 2000, aims to provide a focus of support, education, research, and policy on issues relating to cardiovascular disease within primary care settings.
The EPCCS is a Wonca Europe Special Interest Group (WESIG).
The focus of the EPCCS is directed on the interests of those working within primary care and aims to utilise the considerable evidence base that currently exists and to contribute to extending the evidence base where appropriate.
New literature updates: May 24
- Relative and Cumulative Effects of Lipid and Blood Pressure Control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial.
Stroke. 2009, . click here for abstract
- Impact of High-Dose Atorvastatin in Coronary Heart Disease Patients Age 65 to 78 Years . Clin.Cardiol. 2009, 32:256-263, click here for abstract
- See all selected abstracts, click here
2nd Annual Scientific Meeting of the EPCCS
We are pleased to invite you to participate in the Second Annual Scientific Meeting of the European Primary Care Cardiovascular Society (EPCCS) to be held on
September 3-4, 2009 in Barcelona, Spain.
Following the success and positive feedback from participants, faculty and sponsors on our first meeting held in Amsterdam in 2008 the EPCCS board is convinced our Annual Scientific Meeting will become the EPCCS as the leading pan-European platform that will specifically meet the educational and information needs of GPs, nurses and other healthcare professionals.
The 2009 EPCCS Annual scientific meeting will consist of a Clinical Masterclass where key areas in cardiovascular disease will be addressed such as: hypertension, lipid management, heart failure, obesity & cardiometabolic disease, diabetes, multiple risk management, lifestyle and guidelines. New in the 2009 meeting will be presentations and publications of original scientific papers and per feedback and request of the participants in the 2008 meeting also smaller interactive working group sessions.
About EPCCS
Cardiovascular disease represents the single most important disease presenting to primary care physicians in Europe, based upon its position as the number one cause of death (through myocardial infarction and stroke), the commonest cause of premature death (before the age of 65) and the major cause of disability. Furthermore, cardiovascular disease is a consequent high cost to health care systems throughout Europe, with two of the commonest manifestations of cardiovascular disease, namely stroke and heart failure, occupying the top two most costly conditions to treat.
Read more...
New Literature Updates are added:
On May 4 new literature updates are added on CV Risk and atherosclerosis (week 17) and on Thrombosis (week 17)
This weeks highlighted publication is:
International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme:
Richard Hobbs FD, Gensini G, John Mancini GB, Manolis AJ, Bauer B, Genest J, Feldman RD, Harvey P, Jenssen TG, da Silva PM Eur.J.Cardiovasc.Prev.Rehabil. 2009
BACKGROUND: Single-pill amlodipine/atorvastatin targets the two most common modifiable
Read more...